NFKB1 and colorectal carcinoma: Galectin-4 was found to inhibit tumorigenesis of CRC cells through Wnt/β-catenin signaling pathway and IL-6/NF-κB/STAT3 signaling pathway (Satelli et al., 2011; Kim et al., 2013).